Attana’s presentations from Erik Penser Bank's Bolagsdag and Aktiespararnas Småbolagsdagarna are now available on Attana’s website
The recorded presentations are now uploaded on Attana’s website and can be seen here: https://www.attana.com/investors/#news-press
The presentations can also be seen directly on Youtube using the following links below:
For more information, please contact:
Teodor Aastrup, CEO
+46 (0)8 674 57 00
The Board of directors for Attana consider that the information in this press release is not likely to have a significant effect on the share price but is of general interest for the shareholders and hence should be communicated.
Attana was founded in 2002 with the vision of in vitro characterization of molecular interactions mimicking in vivo conditions. Since then, Attana has developed proprietary label free biosensors for biochemical, crude, sera, and cell-based assays and the Attana Virus Analytics (AVA) platform, a proprietary in vitro diagnostics (IVD) tool. Attana products and research services are used by Big Pharma, biotech companies and academic institutions within the life sciences. To learn more about our latest services and products, please visit www.attana.com or contact email@example.com